These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3266989)

  • 21. The human antiporcine cellular repertoire. In vitro studies of acquired and innate cellular responsiveness.
    Kirk AD; Li RA; Kinch MS; Abernethy KA; Doyle C; Bollinger RR
    Transplantation; 1993 Apr; 55(4):924-31. PubMed ID: 8475569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preexisting antibodies: the clinical relevance of auto-B-lymphocyte antibody and positive B-cell crossmatch.
    Mongkolsuk T; Chiewsilp P; Sujirachato K; Sumethkul V; Jirasiritham S; Chalermsanyakorn P; Danviriyasup K
    Transplant Proc; 1996 Jun; 28(3):1215-6. PubMed ID: 8658631
    [No Abstract]   [Full Text] [Related]  

  • 23. [Lymphocytes not bearing the typical T- and B-cell markers: their characteristics and effector functions].
    Petrov RV; Khalatian NA; Man'ko VM; Leskov VP
    Usp Sovrem Biol; 1980; 90(2):193-210. PubMed ID: 6160687
    [No Abstract]   [Full Text] [Related]  

  • 24. Limited effect of eicosapentaenoic acid on T-lymphocyte and natural killer cell numbers and functions in healthy young males.
    Miles EA; Banerjee T; Wells SJ; Calder PC
    Nutrition; 2006 May; 22(5):512-9. PubMed ID: 16600816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study.
    Joshi SS; Bishop MR; Lynch JC; Tarantolo SR; Abhyankar S; Bierman PJ; Vose JM; Geller RB; McGuirk J; Foran J; Bociek RG; Hadi A; Day SD; Armitage JO; Kessinger A; Pavletic ZS
    Cytotherapy; 2003; 5(6):542-52. PubMed ID: 14660050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-mediated immunity in aged mice: an underlying lesion in IL 2 synthesis.
    Thoman ML; Weigle WO
    J Immunol; 1982 May; 128(5):2358-61. PubMed ID: 6460821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contrasting mechanisms of effector cell activity.
    Gelfand EW; Kardish M
    Transplant Proc; 1978 Jun; 10(2):343-7. PubMed ID: 354124
    [No Abstract]   [Full Text] [Related]  

  • 28. Minimally invasive versus open Roux-en-Y gastric bypass: effect on immune effector cells.
    Whitson BA; D'Cunha J; Hoang CD; Wu B; Ikramuddin S; Buchwald H; Panoskaltsis-Mortari A; Kratzke RA; Miller JS; Maddaus MA
    Surg Obes Relat Dis; 2009; 5(2):181-93. PubMed ID: 18996756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells.
    Kumagai S; Steinberg AD; Green I
    J Clin Invest; 1981 Mar; 67(3):605-14. PubMed ID: 6970750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of host immune response in breast cancer patients.
    Akimoto M; Ishii H; Nakajima Y; Iwasaki H; Tan M; Abe R; Kasai M
    Cancer Detect Prev; 1986; 9(3-4):311-7. PubMed ID: 3488806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Opioid peptides as regulators of the immune system].
    Nasonov EL; Vinogradov VA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):3-10. PubMed ID: 3300699
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunologic effects of blood donation].
    Lange S; Riggert J; Humpe A; Dittmann J; Simson G; Köhler M
    Beitr Infusionsther Transfusionsmed; 1996; 33():93-7. PubMed ID: 8974712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the induction and expression of T cell-mediated immunity. 3. Amplification by papain of the generation of cytotoxic lymphocytes to allogeneic cells.
    Kedar E; Bonavida B
    J Immunol; 1974 Oct; 113(4):1386-9. PubMed ID: 4153487
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of the natural cell mediated and antibody dependent cell mediated cytotoxicity measured as a function of target cell number in patients with mammary tumors and healthy female blood donors.
    Bakaćs T; Garam T; Ringwald G; Tótpál K; Svastits E
    Arch Geschwulstforsch; 1981; 51(4):327-37. PubMed ID: 7316684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocyte functions of child patients with ALL (acute lymphoblastic leukemia) in remission.
    Suzuki M
    Jpn J Clin Oncol; 1984 Mar; 14(1):31-40. PubMed ID: 6231391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclic nucleotides in immunosuppression--neuroendocrine pharmacologic manipulation and in vivo immunoregulation of immunity acting via second messenger systems.
    Strom TB; Carpenter CB
    Transplant Proc; 1980 Jun; 12(2):304-10. PubMed ID: 6249005
    [No Abstract]   [Full Text] [Related]  

  • 37. Cell mediated immunity in liver diseases.
    Bajpai HS; Sen PC; Joseph JK; Agrawal JK
    J Assoc Physicians India; 1979 Apr; 27(4):285-9. PubMed ID: 316814
    [No Abstract]   [Full Text] [Related]  

  • 38. Cell-mediated effector mechanisms in aging humans.
    Marcano NB; Rivas A; Figarella EF; Blanca I; Penchaszadeh GK; Pérez-Rojas G; Bianco NE
    Int Arch Allergy Appl Immunol; 1982; 69(1):7-11. PubMed ID: 6980843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct cell mediated lympholysis in man. Cellular cytotoxic capacity of 100 normal, healthy blood donors.
    Kristensen T; Grunnet N
    Scand J Urol Nephrol; 1975 Mar 6-7; (29 Suppl):45-9. PubMed ID: 1230994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural cytotoxicity and antibody-dependent cytotoxicity in solid tumor cancer patients: regulation by adherent cells.
    DeBoer KP; Braun DP; Harris JE
    Clin Immunol Immunopathol; 1982 Apr; 23(1):133-44. PubMed ID: 6980070
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.